Clinical case of surgical treatment of undifferentiated pleomorphic liver sarcoma
DOI:
https://doi.org/10.30978/GS-2025-3-55Keywords:
undifferentiated pleomorphic liver sarcoma, sarcoma, neoplasmsAbstract
Undifferentiated pleomorphic liver sarcoma (UPS), formerly known as malignant fibrous histiocytoma (MFH), represents a very rare primary hepatic tumour. It was first described by O’Brien and Stout in 1964. This type of tumour is the most prevalent malignant soft tissue tumour, which usually occurs in adulthood and affects the extremities, less commonly the retroperitoneum and abdominal organs.
Objective – to present the treatment outcomes of a rare case of UPS of the liver. The article describes a clinical case of surgical treatment of a patient with UPS of the liver. Patient N., 36 years old, complained of pain in the right hypochondrium, fever, and general weakness. According to the results of instrumental examinations, the clinical diagnosis was made: primary liver tumour, tumour rupture, and intra‑abdominal bleeding. After preoperative preparation, a right‑sided hemihepatectomy, D2 lymphadenectomy, cholecystectomy, and abdominal drainage were performed. The histopathological and immunohistochemical features of the tumour cells were most consistent with undifferentiated pleomorphic liver sarcoma. According to the Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) sarcoma grading system, a total score of 7 (G3) was assigned. The diagnosis was undifferentiated pleomorphic liver sarcoma, pT4aN0M0 G3 stage III, grade 2. Six months later, a CT scan of the abdominal cavity revealed a tumour focus in the right subdiaphragmatic space with invasion of the right diaphragm dome, liver segment IV, and right kidney.
Surgical intervention was performed in volume: viscerolysis, atypical resection of the SgIV liver with right‑sided nephrectomy and resection of the right dome of the diaphragm, aortocaval lymphadissection. Postoperative diagnosis: undifferentiated pleomorphic liver sarcoma rpT4N1(1/2)M0 G3, R0, stage III, grade 2. Currently, the period of recurrence‑free observation is 12 months after the second surgery.
References
Alberti-Flor JJ, O’Hara MF, Weaver F, Evans J, McClure R, Dunn GD.Malignant fibrous histiocytoma of the liver. Gastroenterology. 1985 Oct 1;89(4):890-3. http://doi.org/10.1016/0016-5085(85)90588-8.
Goldblum JR, Weiss SW. Enzinger and Weiss’s Soft Tissue Tumors. 6th edition, Elsevier; 2014.
Huang H, Wu Y, Luo Y. Primary hepatic undifferentiated pleomorphic sarcoma in a young patient. Journal of Gastrointestinal Surgery. 2025 Jan 1;29(1). http://doi.org/10.1016/j.gassur.2024.10.015.
Ma J, Groisberg R, Shao C, Zhong W. Incidence of Undifferentiated Pleomorphic Sarcoma (UPS) in the United States. Sarcoma. 2024;2024(1):6735002. http://doi.org/10.1155/2024/6735002.
Mass J, Talmon G. Undifferentiated pleomorphic sarcoma of liver: case report and review of the literature. Case Reports in Pathology. 2018;2018(1):8031253. http://doi.org/10.1155/2018/8031253.
O’Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer. 1964 Nov;17(11):1445-56. doi: 10.1002/1097-0142(196411)17:11<1445::aid-cncr2820171112>3.0.co;2-g. PMID: 14223761.
Penel N, Coindre JM, Giraud A, et al. Presentation and outcome of frequent and rare sarcoma histologic subtypes: a study of 10,262 patients with localized visceral/soft tissue sarcoma managed in reference centers. Cancer. 2018 Mar 15;124(6):1179-87. http://doi.org/10.1002/cncr.31176.
Wang Z, Liu J, Han J, Yang Z, Wang Q. Analysis of prognostic factors of undifferentiated pleomorphic sarcoma and construction and validation of a prediction nomogram based on SEER database. European Journal of Medical Research. 2022 Sep 15;27(1):179. http://doi.org/10.1186/s40001-022-00810-z.
Wang Z, Xiao Y, Zhang B, Xiaosong L, Shao J, Liao J. Ultrasonographic diagnosis of primary hepatic undifferentiated pleomorphic sarcoma. Journal of Clinical Ultrasound. 2023 Jan;51(1):169-76. http://doi.org/10.1002/jcu.23293.
Yang Y, Hou Y, Yi L, Jiang M, Tang L, Hu M, Xing R. Case report: A rare case of hepatic undifferentiated pleomorphic sarcoma: diagnostic dilemmas and multidisciplinary management strategies. Frontiers in Oncology. 2025 Aug 6;15:1572348. http://doi.org/10.3389/fonc.2025.1572348 PMID: 40842593.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Authors

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
